Study did not demonstrate statistically significant improvement on primary endpoint of reduction in depressive symptoms as measured by MADRS ...

The Threat Intelligence Market is experiencing rapid growth Expected to reach USD 101.14 billion by 2034, CAGR of ...

Heading into Sunday's 67th annual Daytona 500, Richard Childress Racing, a six-time NASCAR Cup Series championship-winning organization, has confirmed to Racing ...

INNOVATE Corp. surged 150% after its subsidiary MediBeacon received FDA approval for its TGFR system. See why I rate VATE ...

If you have idle cash, you can put the money to work earning a great return these days. Here's what the best savings, CD, ...

Microsoft has failed to break technical resistance 3 times in the last 12 months, but recent events in its AI work have ...

Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...

Bristol Myers Squibb announced the Phase 3 RELATIVITY-098 trial evaluating Opdualag (nivolumab and relatlimab-rmbw) for the adjuvant treatment of patients wi ...

New CEO Andre A. Boyd Sr. said he expects Trinity Health Mid-Atlantic will need to invest in infrastructure upgrades at ...

Knownwell, which so far only has one clinic in Boston and another in Dallas, sees a chance to pounce on an unaddressed need ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...